Skip to main content

NephroScan FDA Approval History

FDA Approved: Yes (First approved February 22, 2022)
Brand name: NephroScan
Generic name: technetium Tc 99m succimer
Dosage form: Injection Kit
Treatment for: Diagnosis and Investigation

NephroScan (kit for the preparation of technetium Tc 99m succimer injection) is a radioactive diagnostic agent indicated for use as an aid in the scintigraphic evaluation of renal parenchymal disorders.

Development timeline for NephroScan

Feb 21, 2022Approval FDA Approves NephroScan (Kit for the Preparation of Technetium Tc 99m Succimer Injection) for Radiodiagnostic Imaging

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.